in vivo ≠ in vitro [Power / Sample Size]

posted by Helmut Homepage – Vienna, Austria, 2022-07-25 11:56 (631 d 16:30 ago) – Posting: # 23167
Views: 1,890

Hi Mithu,

❝ Is it advisable to have little large sample size …


Larger than what?

❝ … for molecules falls under BCS Class II and IV? especially when routine 2WC design is selected?


Only in a few cases of BCS class II drugs (under certain conditions) there is an in vivo in vitro correlation. For BCS class IV drugs never. You plan the study always based on the in vivo variability and T/R-ratio for a desired power. In other words, BCS does not play any role.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,984 posts in 4,822 threads, 1,654 registered users;
58 visitors (0 registered, 58 guests [including 6 identified bots]).
Forum time: 04:26 CEST (Europe/Vienna)

Complex, statistically improbable things are by their nature
more difficult to explain than
simple, statistically probable things.    Richard Dawkins

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5